The Global Single-use Pumps in the Biopharmaceutical Market is projected to grow at a CAGR of around 6.21% during the forecast period, 2022-27, says MarkNtel Advisors in their recent research report. With the rising advancement in technology, single-use pumps in bioprocessing systems have become one of the fastest-growing technology used during the manufacturing of biopharma products. Further, it offers various benefits such as low initial investment, high flexibility as compared to the stainless steel systems, the enhanced production quality of biosimilar, etc. As a result, the demand for single-use pump systems has been growing considerably across the globe.
Additionally, the spread of Covid-19 was observed globally by the end of March 2020, resulting in greater concern & awareness in the biotechnology industry, which led to more investment & manufacturing of biologics across the globe. Besides, the market for single-use pumps witnessed increased demand in 2020 due to a rise in the number of clinical trials during the development of vaccines & an increase in pre-commercial product manufacturing globally.
Further, in mid-2020, numerous clinical biotech & healthcare research organizations, such as Pfizer, Bristol-Myers Squibb, Prevention Bio, etc., shifted their focus towards developing the COVID-19 vaccine, which slowed down, the research processes of the conventional vaccine. This resulted in the rise in R&D of the companies related to the clinical production & large-scale manufacturing of COVID-19 vaccines. Hence, the demand for single-use pumps during the development of vaccines witnessed to grow exponentially across the globe.
Upstream Bioprocessing to Hold a Considerable Share in the Market
Based on the bioprocessing type, the market is divided into Upstream & Downstream. Among them, Upstream bioprocessing has grown considerably in recent years since the use of single-use technologies in biopharmaceutical manufacturing & drug development reduces the risk of cross-contamination, scheduling times, and operational efficiencies, thus eliminating the need for switch overtimes. Furthermore, the Peristaltic pumps & tube assemblies are single-use, Gamma-irradiated assemblies designed primarily for upstream bioprocessing. Additionally, the preclinical & clinical sample preparation steps include buffer solution mixing, media preparation, and product transfer to multiple media chambers, all of which are accomplished using single-use pumps. Moreover, lower capital costs & increased process facilities are some of the other attributes supporting the growth of single-use pumps in upstream processing.
Nonetheless, the biopharmaceutical industry is continuously using single-use pumps in the formulation & filing of final solutions. In addition, the rising investments & product innovation for industrial & commercial biopharmaceutical facilities would also propel the market demand for downstream processing during the forecasted years. For instance, in 2021, Quattroflow announced its intention to increase the production of single-use pumps by building a new cleanroom facility in Germany.
North America to Acquire a Significant Share in the Market
Geographically, North America acquired a dominating share in the Global Single-use Pumps market during the historical years. With the increasing demand for biologics & biosimilars in the region, single-use bioprocessing products have been in high demand. Furthermore, biopharmaceutical companies in the region are heavily investing in R&D to explore the use of single-use systems as they offer several advantages, including minimal installation costs, low cross-contamination of products, increased energy efficiency, reduced usage of space, and quick installation.
In addition, the increasing patent expirations of biosimilar drugs have accelerated the R&D activities to introduce new biosimilar in the North American market. Considering this, the governments of the North American region, including the US & Canada has taken several initiatives for the growth of biologics & biosimilar. This had supported various biopharma manufacturers to increase their production capability by making use of single-use bioprocess technology, thereby facilitating the growth of single-use pumps during the forecast years.
Furthermore, the rising investments in the biopharmaceutical industry to combat the requirements of single-use pumps for the fluid delivery in both upstream and downstream processes has increased the growth of single-use pumps in the biopharmaceutical market across North America, reveals MarkNtel Advisors in their research report, "Global Single-Use Pumps in Biopharmaceutical Market Analysis, 2022-2027."
According to MarkNtel Advisors, the leading players in the Global Single-use Pumps in Biopharmaceutical Market are PSG Dover, Quantex Arc, Watson Marlow, Colly Flowtech AB, Levitronix, Pumpcell, Fluid Flow, PROMECON GmbH, CerCell, ALMATECHNIK AG, Verder International B.V., and ProMinent GmbH among others.
Key Questions Answered in the Study